Nephros Inc (NEPH)

$NEPH Good little company that should generate good growth and profitability but good golly what a bush league ”investor day” if thats even what you want to call it. mgmt should attempt short impactful presentations at microcap conferences and 1x1s, which the new team hasn’t even tried. WTF?

$NEPH The water filter market is projected to grow from USD 17.55 billion in 2025 to USD 33.96 billion by 2033 at a CAGR of 8.6%. Nephros Inc. offers the lowest annual costs for water purification, thanks to the long lifespan of its filters (up to 6 months) and minimal maintenance Nephros Inc.: Nephros filters use MediSulfone® technology is particularly valued for its ability to retain particles as small as 0.005 microns, offering high protection against biological contaminants. Nephros filters, such as the DSU-D (Dual Stage Ultra Filter), are designed for water purification in dialysis, with a bacteria and endotoxin removal rate exceeding 99.99%. Their nanofiltration technology ensures water purity surpassing AAMI (Association for the Advancement of Medical Instrumentation) standards for dialysis. Additionally, Nephros filters have an extended lifespan (up to 6 months in some applications), reducing operational costs.

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Nephros Inc. Is that bullish or bearish? $NEPH #Nephros #RsiOverbought #NASDAQ

$NEPH Most of the growth from Q1 was due to the conversion to more recurring/programmatic revenue with lumpy emergency response contributing about 2 cents to EPS. I suspect they are at a normalized run rate of 12 cents in EPS growing 30-40% over the next couple of years. Stock still has a ways to go, IMO.

$NEPH delayed reaction i see

$NEPH Results were strong enough to justify the open... just no volume. Stock is too cheap, this will be rectified in a relatively short amount of time.

$NEPH lol ruthless how they brought that down

$NEPH i'm interested again

$ICU Dialysis machine companies like Fresenius are watching the AKI study. They may have to buy ICU at a huge premium to make up for future lost dialysis machine revenue. Nephros, Braun, and Baxter may also be interested. One day this will be amazing. Enjoy your weekend! $FMS $BAX $NEPH $DVA

$NEPH very small float, any real pressure and this explodes

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Nephros Inc. Is that bullish or bearish? $NEPH #Nephros #RsiOverbought #NASDAQ

$NEPH Agmh very good price to jump in at 0.042 has to get to a dollar soon if I post again mybad we are holding over here..,......

$NEPH legionnaires is no joke In the Med field right now 👀

$NEPH Water filtration tech looking promising. Nephros has solid positioning in medical and commercial markets. Seeing potential for growth, especially with first profitable quarter. Might start a small position to track their progress. balanced analysis of company progress: https://beyondspx.com/article/nephros-neph-a-water-purification-pioneer-navigating-a-transformative-journey

$NEPH - NEPHROS INC - 10K - Updated Risk Factors Company shifts focus to maintaining profitability amid slight revenue decline, new risks from Medica dependency, tariff impacts, and a terminated distribution deal; regulatory focus now on FDA, patent expiration extended to 2044, stock volatility persists. #Risk https://d-risk.ai/NEPH/10-K/2025-03-24

$NEPH This will be interesting when they report given low float and roughly gaap b-even. They more or less said they had some large emergency response business in 4Q without putting numbers around it but the headline growth and profitability should cause a spike even in this shi**y market...

$NEPH can go up

$BTC.X Crypto pick for 2025 is obvious, Bitcoin. Stock pick for 2025 is $NEPH, deep value sleeper. Happy new year all

We want to welcome Nephros to the The Benchmark Company, LLC. 13th Annual Discovery One-on-One Conference, December 11th 2024. See their profile on B2i Digital at https://b2idigital.com/benchmark-13th-annual-discovery-one-on-one-conference Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within medical and commercial markets, offering both proactive and emergency solutions. As a publicly traded company on the Nasdaq (Nasdaq: $NEPH), we consistently demonstrate strong financials, product performance, and value for our shareholders. Nephros is positioned as a technology leader with its unwavering pursuit of enhanced engineering and superior quality control of our FDA 510(k)-cleared Class II infection control water filters. We look forward to seeing the continued results from Robert Banks, Judy Krandel, CFA, Michael Milman, Vashone T., Judy Mazzini, Brianne McGuire, Devorah Serkin, Alfred Vargas the entire Nephros team! Benchmark, headquartered in New York City, is a full-service investment banking firm offering comprehensive corporate finance, advisory, and institutional brokerage services. Thanks to the exceptional team at The Benchmark Company, LLC. for organizing this conference: Richard Messina, Michael Fiorini, John Borer, Vince Curatola, Edward Rubin, Michael Jacobs, Jacqueline Messina, Jennifer Scutti, William Sutherland, Joseph Kronk, and many others. For more information on The Benchmark Company, LLC., please visit https://www.benchmarkcompany.com/

$NEPH Nephros Inc. (NEPH): Driving Innovation in Water Filtration for Medical and Commercial Sectors https://beyondspx.com/article/nephros-inc-neph-driving-innovation-in-water-filtration-for-medical-and-commercial-sectors

$NEPH this company making some money with the hurricanes?

$NEPH still a turd